Cargando…
Adverse Drug Reactions in Norway: A Systematic Review
Prescription medicines aim to relieve patients’ suffering but they can be associated with adverse side effects or adverse drug reactions (ADRs). ADRs are an important cause of hospital admissions and a financial burden on healthcare systems across the globe. There is little integrative and collectiv...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789571/ https://www.ncbi.nlm.nih.gov/pubmed/31349705 http://dx.doi.org/10.3390/pharmacy7030102 |
_version_ | 1783458648773623808 |
---|---|
author | Vaismoradi, Mojtaba Logan, Patricia A. Jordan, Sue Sletvold, Hege |
author_facet | Vaismoradi, Mojtaba Logan, Patricia A. Jordan, Sue Sletvold, Hege |
author_sort | Vaismoradi, Mojtaba |
collection | PubMed |
description | Prescription medicines aim to relieve patients’ suffering but they can be associated with adverse side effects or adverse drug reactions (ADRs). ADRs are an important cause of hospital admissions and a financial burden on healthcare systems across the globe. There is little integrative and collective knowledge on ADR reporting and monitoring in the Norwegian healthcare system. Accordingly, this systematic review aims to investigate the current trends in ADR reporting, monitoring, and handling in the Norwegian healthcare system and describe related interventions. Appropriate keywords, with regard to ADRs in both English and Norwegian languages, were used to retrieve articles published from 2010 to 2019. Six articles met the inclusion criteria. The findings offer a comprehensive picture of ADR reporting and monitoring in the Norwegian healthcare system. Psychotropic medicines were most commonly implicated by patients, while professionals most commonly reported ADRs associated with anticoagulants. The current ADR systems were compiled with the involvement of both patients and healthcare providers to record all types of drugs and ADRs of various severities, and aimed at improving ADR tracking. However, there is a need to improve current initiatives in terms of feedback and quality, and more studies are needed to explore how ADR profiles, and the associated vigilance, can improve the safety of medicines management in Norway. |
format | Online Article Text |
id | pubmed-6789571 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-67895712019-10-16 Adverse Drug Reactions in Norway: A Systematic Review Vaismoradi, Mojtaba Logan, Patricia A. Jordan, Sue Sletvold, Hege Pharmacy (Basel) Review Prescription medicines aim to relieve patients’ suffering but they can be associated with adverse side effects or adverse drug reactions (ADRs). ADRs are an important cause of hospital admissions and a financial burden on healthcare systems across the globe. There is little integrative and collective knowledge on ADR reporting and monitoring in the Norwegian healthcare system. Accordingly, this systematic review aims to investigate the current trends in ADR reporting, monitoring, and handling in the Norwegian healthcare system and describe related interventions. Appropriate keywords, with regard to ADRs in both English and Norwegian languages, were used to retrieve articles published from 2010 to 2019. Six articles met the inclusion criteria. The findings offer a comprehensive picture of ADR reporting and monitoring in the Norwegian healthcare system. Psychotropic medicines were most commonly implicated by patients, while professionals most commonly reported ADRs associated with anticoagulants. The current ADR systems were compiled with the involvement of both patients and healthcare providers to record all types of drugs and ADRs of various severities, and aimed at improving ADR tracking. However, there is a need to improve current initiatives in terms of feedback and quality, and more studies are needed to explore how ADR profiles, and the associated vigilance, can improve the safety of medicines management in Norway. MDPI 2019-07-25 /pmc/articles/PMC6789571/ /pubmed/31349705 http://dx.doi.org/10.3390/pharmacy7030102 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Vaismoradi, Mojtaba Logan, Patricia A. Jordan, Sue Sletvold, Hege Adverse Drug Reactions in Norway: A Systematic Review |
title | Adverse Drug Reactions in Norway: A Systematic Review |
title_full | Adverse Drug Reactions in Norway: A Systematic Review |
title_fullStr | Adverse Drug Reactions in Norway: A Systematic Review |
title_full_unstemmed | Adverse Drug Reactions in Norway: A Systematic Review |
title_short | Adverse Drug Reactions in Norway: A Systematic Review |
title_sort | adverse drug reactions in norway: a systematic review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789571/ https://www.ncbi.nlm.nih.gov/pubmed/31349705 http://dx.doi.org/10.3390/pharmacy7030102 |
work_keys_str_mv | AT vaismoradimojtaba adversedrugreactionsinnorwayasystematicreview AT loganpatriciaa adversedrugreactionsinnorwayasystematicreview AT jordansue adversedrugreactionsinnorwayasystematicreview AT sletvoldhege adversedrugreactionsinnorwayasystematicreview |